Nadinda A M van der Ende
Overview
Explore the profile of Nadinda A M van der Ende including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luijten S, van der Ende N, Cornelissen S, Kluijtmans L, van Hattem A, Lycklama A Nijeholt G, et al.
Neuroradiology
. 2023 Jun;
65(11):1649-1655.
PMID: 37380891
Purpose: Diffusion-weighted imaging (DWI) b0 may be able to substitute T2*-weighted gradient echo (GRE) or susceptibility-weighted imaging (SWI) in case of comparable detection of intracranial hemorrhage (ICH), thereby reducing MRI...
2.
van der Ende N, Roozenbeek B, Smagge L, Luijten S, Aerden L, Kraayeveld P, et al.
JAMA Neurol
. 2023 May;
80(7):714-722.
PMID: 37213122
Importance: Dual thrombolytic treatment with small bolus alteplase and mutant prourokinase has the potential to be a safer and more efficacious treatment for ischemic stroke than alteplase alone because mutant...
3.
van der Ende N, Luijten S, Kluijtmans L, Postma A, Cornelissen S, van Hattem A, et al.
Stroke
. 2023 May;
54(6):1587-1592.
PMID: 37154054
Background: The Heidelberg Bleeding Classification, developed for computed tomography, is also frequently used to classify intracranial hemorrhage (ICH) on magnetic resonance imaging. Additionally, the presence of any ICH is frequently...
4.
van der Ende N, Kremers F, van der Steen W, Venema E, Kappelhof M, Majoie C, et al.
Stroke
. 2023 Jan;
54(2):476-487.
PMID: 36689584
Background: Symptomatic intracranial hemorrhage (sICH) is a severe complication of reperfusion therapy for ischemic stroke. Multiple models have been developed to predict sICH or intracranial hemorrhage (ICH) after reperfusion therapy....
5.
van der Ende N, den Hartog S, Broderick J, Khatri P, Visser-Meily J, van Leeuwen N, et al.
Neurology
. 2023 Jan;
100(13):e1321-e1328.
PMID: 36599699
Background And Objectives: The EuroQol Group 5-Dimension Self-Reported Questionnaire (EQ-5D) is a well-established instrument to assess quality of life and generates generic utility values for health states reported by patients,...
6.
Samuels N, Compagne K, van der Ende N, Chalos V, Konduri P, van Doormaal P, et al.
J Stroke Cerebrovasc Dis
. 2022 Dec;
32(2):106906.
PMID: 36473395
Objectives: The beneficial effect of endovascular thrombectomy (EVT) on clinical outcome is assumed to be caused by reduced follow-up infarct volume (FIV), which could serve as an early imaging endpoint....
7.
van der Steen W, van der Ende N, Luijten S, Rinkel L, van Kranendonk K, van Voorst H, et al.
J Neurointerv Surg
. 2022 Oct;
15(10):971-976.
PMID: 36261280
Background: Intracranial hemorrhage (ICH) is a frequent complication after endovascular stroke treatment. Objective: To assess the association of the occurrence and type of ICH after endovascular treatment (EVT) with functional...
8.
van der Ende N, Roozenbeek B, Smagge L, Luijten S, Aerden L, Kraayeveld P, et al.
Trials
. 2022 Aug;
23(1):641.
PMID: 35945566
Background: The effectiveness of alteplase for ischemic stroke treatment is limited, partly due to the occurrence of intracranial and extracranial hemorrhage. Mutant pro-urokinase (m-proUK) does not deplete fibrinogen and lyses...
9.
van der Steen W, van der Ende N, van Kranendonk K, Chalos V, van Oostenbrugge R, van Zwam W, et al.
Stroke
. 2022 Jun;
53(9):2818-2827.
PMID: 35674042
Background: Symptomatic intracranial hemorrhage (sICH) is a serious complication after endovascular treatment for ischemic stroke. We aimed to identify determinants of its occurrence and location. Methods: We retrospectively analyzed data...
10.
van der Ende N, Roozenbeek B, Berkhemer O, Koudstaal P, Boiten J, van Dijk E, et al.
Stroke
. 2021 Oct;
53(1):61-69.
PMID: 34607469
Background And Purpose: Blinded outcome assessment in trials with prospective randomized open blinded end point design is challenging. Unblinding can result in misclassified outcomes and biased treatment effect estimates. An...